Drug research

Saline

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the KneeNCT03485157	MDXG	Phase 2	Completed	2022-04-19Actual
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee OsteoarthritisNCT05796765	MDXG	Phase 2	Terminated	2023-12-15Actual
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)NCT04042844	BioRestorative Therapies	Phase 2	Recruiting	2026-12Estimated
Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainNCT06325566	MESO	Phase 3	Active not recruiting	2027-07Estimated

MDXGCompletedPrimary completion: 2022-04-19 · Actual

Trial details

MDXGTerminatedPrimary completion: 2023-12-15 · Actual

Trial details

BioRestorative TherapiesRecruitingPrimary completion: 2026-12 · Estimated

Trial details

MESOActive not recruitingPrimary completion: 2027-07 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.